Astellas Pharma Inc.:企業のM&A・事業提携・投資動向

◆英語タイトル:Astellas Pharma Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C2038
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:132
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Astellas Pharma Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Astellas Pharma Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Astellas Pharma Inc. since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Astellas Pharma Inc.’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Astellas Pharma Inc.. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Astellas Pharma Inc.’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Astellas Pharma Inc. and its subsidiaries since 2007.
- Information about key financial and legal advisors for Astellas Pharma Inc.’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Astellas Pharma Inc.’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 6
LIST OF FIGURES 6
TARGETS AND PARTNERS 7
MERGERS & ACQUISITIONS 14
Mergers and Acquisitions – Overview 14
Mergers and Acquisitions – Deal reports 15
CORPORATE VENTURING 22
Corporate Venturing – Overview 22
Corporate Venturing – Deal reports 23
PARTNERSHIP 27
Partnership – Overview 27
Partnership – Deal reports 28
DIVESTMENTS 117
Divestments – Overview 117
Divestments – Deal reports 118
APPENDIX 122
Contact Us 122
About MarketLine Financial Deals Database 122
Deal Definition and Methodology 124
About MarketLine 131

List of Tables
Table 1: Astellas Pharma Inc M&A volume and value trend (2014-YTD2018)
Table 2: Astellas Pharma Inc M&A activity by geography (2014-YTD2018)
Table 3: Astellas Pharma Inc corporate venturing volume and value trend (2014-YTD2018)
Table 4: Astellas Pharma Inc corporate venturing by geography (2014-YTD2018)
Table 5: Astellas Pharma Inc partnership volume and value trend (2014-YTD2018)
Table 6: Astellas Pharma Inc partnership trend by key deal type (2014-YTD2018)
Table 7: Astellas Pharma Inc divestments volume and value trend (2014-YTD2018)

List of Figures
Figure 1: Astellas Pharma Inc M&A volume and value trend (2014-YTD2018)
Figure 2: Astellas Pharma Inc M&A activity by geography (2014-YTD2018)
Figure 3: Astellas Pharma Inc corporate venturing volume and value trend (2014-YTD2018)
Figure 4: Astellas Pharma Inc corporate venturing by geography (2014-YTD2018)
Figure 5: Astellas Pharma Inc partnership volume and value trend (2014-YTD2018)
Figure 6: Astellas Pharma Inc partnership trend by key deal type (2014-YTD2018)
Figure 7: Astellas Pharma Inc divestments volume and value trend (2014-YTD2018)

★海外企業調査レポート[Astellas Pharma Inc.:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Genoptix Inc:医療機器:M&Aディール及び事業提携情報
    Summary Genoptix Inc (Genoptix) is a hematopathology center which provides oncology diagnostics and informatics services specializing in hematology and solid tumors. The center offers biopharma and healthcare laboratory, discovery, drug development, care and cost development, and patient services. G …
  • Aevi Genomic Medicine Inc (GNMX):医療機器:M&Aディール及び事業提携情報
    Summary Aevi Genomic Medicine Inc (Aevi), formerly Medgenics Inc is a research and development company that discovers and develops novel therapies for pediatric onset and life-altering diseases.The company provides pipeline products such as AEVI-001 and AEVI-002. Its lead product AEVI-001, is a glut …
  • Lagardere Travel Retail S.A.S:企業の戦略・SWOT・財務情報
    Lagardere Travel Retail S.A.S - Strategy, SWOT and Corporate Finance Report Summary Lagardere Travel Retail S.A.S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Metro Inc.:企業の戦略・SWOT・財務情報
    Metro Inc. - Strategy, SWOT and Corporate Finance Report Summary Metro Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Success Universe Group Limited
    Success Universe Group Limited - Strategy, SWOT and Corporate Finance Report Summary Success Universe Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Wageningen University-製薬・医療分野:企業M&A・提携分析
    Summary Wageningen University (WU), a subsidiary of Wageningen University and Research Centre, is an education and research institution. The university offers bachelors’, masters’ and PhD programs. It specializes in healthy food and living environment domain. WU offers various courses in bachelor of …
  • Sterling Energy plc (SEY):企業の財務・戦略的SWOT分析
    Summary Sterling Energy Plc (Sterling) is an oil and gas company that offers oil and gas exploration and development services. The company acquires, produces, operates, manages, and develops crude oil and natural gas producing assets. It operates and manages oil and gas exploration projects such as …
  • Milagen Inc:企業の製品パイプライン分析
    Summary Milagen Inc (Milagen) is a medical device company. It provides diagnostic products. The company generates antibody reagents against the human proteome. It discovers, develops and markets non invasive immunodiagnostic products for monitoring, surveillance and detection of cancers. Milagen off …
  • Southern Co:発電所・企業SWOT分析
    Southern Co - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (execut …
  • Woolworths Ltd (WOW):企業の財務・戦略的SWOT分析
    Woolworths Ltd (WOW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • China Telecom Corporation Limited:企業の戦略・SWOT・財務情報
    China Telecom Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary China Telecom Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Shiseido Company, Limited:戦略・SWOT・企業財務分析
    Shiseido Company, Limited - Strategy, SWOT and Corporate Finance Report Summary Shiseido Company, Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Antero Resources Corp (AR):企業の財務・戦略的SWOT分析
    Antero Resources Corp (AR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Travere Therapeutics Inc (TVTX):企業の財務・戦略的SWOT分析
    Travere Therapeutics Inc (TVTX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Amadeus IT Group S.A.:企業の戦略・SWOT・財務情報
    Amadeus IT Group S.A. - Strategy, SWOT and Corporate Finance Report Summary Amadeus IT Group S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • RWE AG (RWE):企業の財務・戦略的SWOT分析
    RWE AG (RWE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pote …
  • Panmure Gordon & Co Limited (PMR):企業の財務・戦略的SWOT分析
    Panmure Gordon & Co Limited (PMR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Vectrus Inc (VEC):企業の財務・戦略的SWOT分析
    Vectrus Inc (VEC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Tethys Petroleum Ltd (TPL.H):石油・ガス:M&Aディール及び事業提携情報
    Summary Tethys Petroleum Ltd (Tethys) is an independent oil and gas exploration and production company. It focuses on projects in Central Asia and the Caspian Region. The company has a portfolio of assets, including existing oil and gas production, frontier high impact exploration and unconventional …
  • Innovation Pharmaceuticals Inc (IPIX):医療機器:M&Aディール及び事業提携情報
    Summary Innovation Pharmaceuticals Inc (Innovation Pharmaceuticals), formerly Cellceutix Corp, is a biopharmaceutical company that discovers and advances medical therapies with dermatology, oncology, anti-inflammatory and antibiotic applications. The company provides pipeline products such as kevetr …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆